Vibrant Therapeutics
PrivateLast Round
Series B
Jan 12, 2026
Total Funding Raised
$64.35M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Vibrant Therapeutics is a biotechnology company that develops intelligent, logic-gated therapeutics designed to selectively activate in the desired disease microenvironment.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vibrant Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Vibrant Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jan 12, 2026 | ||||
| Series A Extension | Aug 25, 2025 | ||||
| Series A | Aug 25, 2025 | ||||
| Series A | Jul 19, 2023 |
Vibrant Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| First Principle Venture Limited | Series B |
| Advantage Capital | Series A |
| Northern Light Venture Capital | Series B |
| Bayland Capital | Series B |
| HongShan | Series A, Series B |
| Trinity Innovation Fund | Series A |
| Pfizer Ventures | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 15, 2026
Monthly visitors grew 292% MoM, from 275 to 1.1K.
- Jan 15, 2026
Han Lee appointed co-chief executive officer alongside founder Larry Wang.
Vibrant Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Vibrant Therapeutics's valuation, stock price, and market status.